Navigation Links
Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
Date:5/26/2008

argement of the liver and spleen. In some cases, central nervous system involvement leads to progressive neurologic decline.

Shire Human Genetic Therapies is actively tracking health data among individuals affected by Hunter syndrome as part of the company's long-term outcome survey, called the Hunter Outcome Survey (HOS). HOS is designed to support the gathering, analysis, reporting and sharing of data from around the world about Hunter syndrome. Shire believes that the inclusion of all people affected by Hunter syndrome, whether on therapy or not, and the analysis and dissemination of this information will allow for further understanding of Hunter syndrome and disease education on a global scale.

Shire Limited

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertaint
'/>"/>

SOURCE Shire Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
2. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
3. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
4. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
5. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
6. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
7. BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials
8. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
9. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
10. Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
11. PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014 MiMedx Group, Inc. (NASDAQ: ... human amniotic tissue and patent-protected processes to develop and ... Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors ... Ph.D., Chief Scientific Officer, will present at the Stem ... on Tuesday, October 7, 2014, at 5:00PM Pacific Daylight ...
(Date:9/30/2014)... NEW YORK , Sept. 30, 2014 /PRNewswire/ ... - 2014 Summary Global Markets Direct,s, ... 2014, provides an overview of the Arbor Pharmaceuticals, ... report provides comprehensive information on the current therapeutic ... comparative analysis at various stages, therapeutics assessment by ...
(Date:9/30/2014)... , Sept. 30, 2014  According to ... world of cancer clinical trials is going through ... trials and the work of the current clinical ... types of ,next generation, clinical trials, which will ... The company has been recognized ...
Breaking Medicine Technology:MiMedx to Present at the Stem Cell Meeting on the Mesa 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 3Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2
(Date:10/1/2014)... 2014 NoteSwift Inc., announced today their ... 12.1 and 13.0. NoteSwift is the bridge between the ... navigate and document clinical information at the point of ... a patient note by more than half – and ... pain points providers state impedes EHR use according to ...
(Date:10/1/2014)... On Sept. 9, Chapín Coffee was selected ... Stewart American Made Awards (MSAMAs), an annual competition in ... the fields of crafts, design, food and style. ... in the MSAMAs, which celebrates entrepreneurs and artisans who ... communities and changing the way we shop, work and ...
(Date:10/1/2014)... Deland, Florida (PRWEB) October 01, 2014 ... to promote awareness and early detection plans while raising ... to support Breast Cancer Awareness Month in ... Water also wants to promote the importance of having ... contaminated drinking water may be linked to certain forms ...
(Date:10/1/2014)... 2014 Today marks the final day ... Institute in Oxnard and Woodland Hills, Calif., is in ... rehabilitation training. , “Speaking to this group of specialists ... to get the help and care they deserve,” Dr. ... previous dental work, providing cosmetic dentistry, correcting bite issues, ...
(Date:10/1/2014)... After undergoing a trial-and-error process in an ... join, Living Well Assisted Living at Home recently joined ... the home of its headquarters. , Although Living Well’s ... thought of adding one more activity to their busy ... the right chamber to join because membership in the ...
Breaking Medicine News(10 mins):Health News:NoteSwift Joins Allscripts Developer Program 2Health News:NoteSwift Joins Allscripts Developer Program 3Health News:Chicago Coffee Start-up Makes a Big Impact, Earns National Recognition 2Health News:Pelican Water Supports Breast Cancer Awareness Month with Order Donations 2Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 2Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 3Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 4Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 5Health News:Living Well Joins San Rafael Chamber of Commerce 2Health News:Living Well Joins San Rafael Chamber of Commerce 3
... encourage health care providers to take into account the number ... tumor cells in colon cancer patients, taken during follow up. ... of reccurence , as this number was shown to ... comeback. ,Lymph node evaluation is important for determining ...
... by addiction specialists and published in Lancet Medical journal, tobacco ... drugs. Prof David Nutt from Bristol University headed this research. ... fifth most dangerous drug followed by ketamine, speed and safety. ... less harmful than tobacco and is recently downgraded to class ...
... in the United States has urged drug companies to print ... treat sleep disorder. FDA has also ordered the companies to ... ,Last week the FDA had underlined the harmful effects of ... incidents of weird behavior like cooking food, eating and even ...
... conducted by Dr. Steriani Elavsky, women passing through their menopause ... they exercised. The improvements in heart and respiratory fitness are ... of life. ,This research was carried out on ... on a random basis. One group was assigned to perform ...
... all private hospitals, built on subsidised government land, must ... indoor and outdoor facilities or face contempt of court ... poor "obligatory" at hospitals built on subsidised land, a ... Malhotra said the hospitals are obliged to provide free ...
... World Health Organisation (WHO) has claimed that the global tuberculosis ... it declared TB a public health emergency in 1993. // ... before the world TB day, says that the percentage ... but has held steady in 2005. ,United Nations ...
Cached Medicine News:Health News:Doctors Warned to Keep Track of Tumorous Lymph Nodes 2Health News:Private Clinics on Public Land Must Treat Poor Free: Court 2Health News:Global Tuberculosis Epidemic Levelling Off - WHO 2
... femoral option and tibial insert which provides a ... degrees of flexion to induce a smooth stable ... of flexion. Femoral component comes in a PS ... constrained tibial insert in conjunction with the femur ...
... True to its leadership role within the ... clinical experience of the industry's leading fixed-bearing ... Knee System, with the clinically proven technology ... leading rotating platform knee. ,The result is ...
... The Femoral component of ... soft tissue and bony destruction ... a high rate of long ... for minimum bone resection and ...
... Knee System is taking total knee replacement to ... of clinical experience. One thing has become clear ... several choices for their patients. Surgeon choice ... factor in long-term patient satisfaction. Biomet responded to ...
Medicine Products: